1. Cihan YB. Significance of ABO-Rh blood groups in response and prognosis in breast cancer patients treated with radiotherapy and chemotherapy. Asian Pac J Cancer Prev. 2014;15(9):4055-60.10.7314/APJCP.2014.15.9.4055
2. Solak M, Turkoz FP, Keskin O, Aksoy S, Babacan T, Sarici F, et al. The lymph node ratio as an independent prognostic factor for non metastatic node-positive breast cancer recurrence and mortality. J BUON. 2015; 20:737-45.
3. Fisher B, Redmond C, Wickerham DL, Wolmark N, Bowman D, Couture J, et al. Systemic therapy in patients with node-negative breast cancer: a commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Ann Intern Med. 1989;111(9):703-12.10.7326/0003-4819-111-9-7032679288
4. Liu D, Chen Y, Deng M, Xie G, Wang J, Zhang L, et al. Lymph node ratio and breast cancer prognosis: a metaanalysis. Breast Cancer. 2014;21(1):1-9.10.1007/s12282-013-0497-824101545
5. Fortin A, Dagnault A, Blondeau L, Vu TT, Larochelle M. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation. Int J Radiat Oncol Biol Phys. 2006;65(1):33-9.10.1016/j.ijrobp.2005.12.01416542789
6. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud- Caspar I, Rapiti E, Vlastos G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27(7):1062-8.10.1200/JCO.2008.18.696519164210
7. Wu SG, Chen Y, Sun JY, Li FY, Lin Q, Lin HX, et al. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy. Radiat Oncol. 2013;8:119.10.1186/1748-717X-8-119369184823672513
8. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, Buchholz TA. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter- institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the MD Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 2007;68(1):59-65.10.1016/j.ijrobp.2006.12.01717321065
9. Karlsson P, Cole BF, Price KN, Coates AS, Castiglione- Gertsch M, Gusterson BA, et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol. 2007;25(15): 2019-26.10.1200/JCO.2006.09.815217420511